Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
5350
Trial Sponsor
Clinical Trial Start Date
2013
0Primary Completion Date
2015
0Study Completion Date
2015
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
sitagliptin0
ITCA 650 60 mcg/day0
Interventional Trial Phase
Phase 30
Official Name
A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Sitagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes0
Last Updated
June 2, 2016
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Quadruple0
Masked Party
Participant0
Outcomes Assessor0
Investigator0
Care Provider0
Study summary
Phase 3 study to compare treatment with ITCA 650 to sitagliptin when added to metformin monotherapy in patients with type 2 diabetes.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
